1 / 1

Ticlopidine in Cardiovascular Disease: A Clinical Overview

Explore randomized, controlled phase III trials of ticlopidine in cardiovascular disease to understand past, present, and future implications of platelet ADP-receptor antagonists. This study highlights the efficacy and safety profiles.

xavier-potts
Télécharger la présentation

Ticlopidine in Cardiovascular Disease: A Clinical Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 2 A summary of randomized, controlled, phase III trials of ticlopidine in cardiovascular disease Raju NC et al. (2008) Platelet ADP-receptor antagonists for cardiovascular disease: past, present and futureNat Clin Pract Cardiovasc Med doi:10.1038/ncpcardio1372

More Related